Prospective Arm of Conduct - Edwards SAPIEN3 PPI Registry (Conduct-pro)
Edwards SAPIEN 3 PPI Registry - A Retrospective Survey and Prospective Identification of Procedure Related Variables Associated With Permanent Pacemaker Implantation in Patients Receiving an Edwards SAPIEN 3 Valve
Sponsor: Edwards Lifesciences
A observational or N/A phase clinical study on AV Block and Aortic Valve Stenosis, this trial is completed. The trial is conducted by Edwards Lifesciences and has accumulated 10 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jul 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2023 — Jul 2023 [monthly]
Active Not Recruiting
▶ Show 5 earlier versions
-
Jun 2022 — Apr 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Jun 2022 [monthly]
Recruiting
-
Oct 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2019 — Oct 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Mar 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Edwards Lifesciences
- Institut für Pharmakologie und Präventive Medizin
For direct contact, visit the study record on ClinicalTrials.gov .